カテゴリ： 世界, 医療/バイオ, Market Monitor Global

低分子医薬品有効成分（API）のグローバル市場展望 2023年-2029年：標準原薬、高効能原薬

■ 英語タイトル：Small Molecule Active Pharmaceutical Ingredient Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8667）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8667
■ 発行日：2023年7月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：128
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥481,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥625,300見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥721,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[低分子医薬品有効成分（API）のグローバル市場展望 2023年-2029年：標準原薬、高効能原薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の低分子医薬品有効成分（API）市場規模と予測を収録しています。・世界の低分子医薬品有効成分（API）市場：売上、2018年-2023年、2024年-2029年
・世界の低分子医薬品有効成分（API）市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の低分子医薬品有効成分（API）市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「標準原薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

低分子医薬品有効成分（API）のグローバル主要企業は、Johnson Matthey、 Siegfried Holding AG、 Pfizer、 Sanofi S.A.、 Novartis AG,、 Bristol-Myers Squibb、 Boehringer Ingelheim GmbH、 GlaxoSmithKline、 Albany Molecular Research Inc.、 Bachem Holding AG、 PCAS、 Patheon N.V.、 AstraZeneca、 Johnson & Johnson、 Merck & Co、 BASF SE、 Catalent Inc.、 Teva Pharmaceuticals、 Roche、 Cambrex Corporation、 GILEAD Science Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、低分子医薬品有効成分（API）のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の低分子医薬品有効成分（API）市場：タイプ別、2018年-2023年、2024年-2029年
世界の低分子医薬品有効成分（API）市場：タイプ別市場シェア、2022年
・標準原薬、高効能原薬

世界の低分子医薬品有効成分（API）市場：用途別、2018年-2023年、2024年-2029年
世界の低分子医薬品有効成分（API）市場：用途別市場シェア、2022年
・心血管疾患、呼吸器疾患、感染症、その他

世界の低分子医薬品有効成分（API）市場：地域・国別、2018年-2023年、2024年-2029年
世界の低分子医薬品有効成分（API）市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における低分子医薬品有効成分（API）のグローバル売上、2018年-2023年
・主要企業における低分子医薬品有効成分（API）のグローバル売上シェア、2022年
・主要企業における低分子医薬品有効成分（API）のグローバル販売量、2018年-2023年
・主要企業における低分子医薬品有効成分（API）のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Johnson Matthey、 Siegfried Holding AG、 Pfizer、 Sanofi S.A.、 Novartis AG,、 Bristol-Myers Squibb、 Boehringer Ingelheim GmbH、 GlaxoSmithKline、 Albany Molecular Research Inc.、 Bachem Holding AG、 PCAS、 Patheon N.V.、 AstraZeneca、 Johnson & Johnson、 Merck & Co、 BASF SE、 Catalent Inc.、 Teva Pharmaceuticals、 Roche、 Cambrex Corporation、 GILEAD Science Inc.

*************************************************************

・調査・分析レポートの概要
低分子医薬品有効成分（API）市場の定義
市場セグメント
世界の低分子医薬品有効成分（API）市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の低分子医薬品有効成分（API）市場規模
世界の低分子医薬品有効成分（API）市場規模：2022年 VS 2029年
世界の低分子医薬品有効成分（API）市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの低分子医薬品有効成分（API）の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の低分子医薬品有効成分（API）製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：標準原薬、高効能原薬
低分子医薬品有効成分（API）のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：心血管疾患、呼吸器疾患、感染症、その他
低分子医薬品有効成分（API）の用途別グローバル売上・予測

・地域別市場分析
地域別低分子医薬品有効成分（API）市場規模 2022年と2029年
地域別低分子医薬品有効成分（API）売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Johnson Matthey、 Siegfried Holding AG、 Pfizer、 Sanofi S.A.、 Novartis AG,、 Bristol-Myers Squibb、 Boehringer Ingelheim GmbH、 GlaxoSmithKline、 Albany Molecular Research Inc.、 Bachem Holding AG、 PCAS、 Patheon N.V.、 AstraZeneca、 Johnson & Johnson、 Merck & Co、 BASF SE、 Catalent Inc.、 Teva Pharmaceuticals、 Roche、 Cambrex Corporation、 GILEAD Science Inc.
...

This report aims to provide a comprehensive presentation of the global market for Small Molecule Active Pharmaceutical Ingredient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Active Pharmaceutical Ingredient. This report contains market size and forecasts of Small Molecule Active Pharmaceutical Ingredient in global, including the following market information:
Global Small Molecule Active Pharmaceutical Ingredient Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Small Molecule Active Pharmaceutical Ingredient Market Sales, 2018-2023, 2024-2029, (MT)
Global top five Small Molecule Active Pharmaceutical Ingredient companies in 2022 (%)
The global Small Molecule Active Pharmaceutical Ingredient market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Standard API Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Small Molecule Active Pharmaceutical Ingredient include Johnson Matthey, Siegfried Holding AG, Pfizer, Sanofi S.A., Novartis AG,, Bristol-Myers Squibb, Boehringer Ingelheim GmbH, GlaxoSmithKline and Albany Molecular Research Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Small Molecule Active Pharmaceutical Ingredient manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Small Molecule Active Pharmaceutical Ingredient Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Small Molecule Active Pharmaceutical Ingredient Market Segment Percentages, by Type, 2022 (%)
Standard API
High Potency API
Global Small Molecule Active Pharmaceutical Ingredient Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Small Molecule Active Pharmaceutical Ingredient Market Segment Percentages, by Application, 2022 (%)
Cardiovascular Diseases
Respiratory Disorders
Infectious Diseases
Others
Global Small Molecule Active Pharmaceutical Ingredient Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Small Molecule Active Pharmaceutical Ingredient Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Molecule Active Pharmaceutical Ingredient revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Small Molecule Active Pharmaceutical Ingredient revenues share in global market, 2022 (%)
Key companies Small Molecule Active Pharmaceutical Ingredient sales in global market, 2018-2023 (Estimated), (MT)
Key companies Small Molecule Active Pharmaceutical Ingredient sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson Matthey
Siegfried Holding AG
Pfizer
Sanofi S.A.
Novartis AG,
Bristol-Myers Squibb
Boehringer Ingelheim GmbH
GlaxoSmithKline
Albany Molecular Research Inc.
Bachem Holding AG
PCAS
Patheon N.V.
AstraZeneca
Johnson & Johnson
Merck & Co
BASF SE
Catalent Inc.
Teva Pharmaceuticals
Roche
Cambrex Corporation
GILEAD Science Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Small Molecule Active Pharmaceutical Ingredient, market overview.
Chapter 2: Global Small Molecule Active Pharmaceutical Ingredient market size in revenue and volume.
Chapter 3: Detailed analysis of Small Molecule Active Pharmaceutical Ingredient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Small Molecule Active Pharmaceutical Ingredient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Small Molecule Active Pharmaceutical Ingredient capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Small Molecule Active Pharmaceutical Ingredient Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Molecule Active Pharmaceutical Ingredient Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Molecule Active Pharmaceutical Ingredient Overall Market Size
2.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size: 2022 VS 2029
2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Small Molecule Active Pharmaceutical Ingredient Sales: 2018-2029
3 Company Landscape
3.1 Top Small Molecule Active Pharmaceutical Ingredient Players in Global Market
3.2 Top Global Small Molecule Active Pharmaceutical Ingredient Companies Ranked by Revenue
3.3 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Companies
3.4 Global Small Molecule Active Pharmaceutical Ingredient Sales by Companies
3.5 Global Small Molecule Active Pharmaceutical Ingredient Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Small Molecule Active Pharmaceutical Ingredient Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
3.8 Tier 1, Tier 2 and Tier 3 Small Molecule Active Pharmaceutical Ingredient Players in Global Market
3.8.1 List of Global Tier 1 Small Molecule Active Pharmaceutical Ingredient Companies
3.8.2 List of Global Tier 2 and Tier 3 Small Molecule Active Pharmaceutical Ingredient Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Small Molecule Active Pharmaceutical Ingredient Market Size Markets, 2022 & 2029
4.1.2 Standard API
4.1.3 High Potency API
4.2 By Type – Global Small Molecule Active Pharmaceutical Ingredient Revenue & Forecasts
4.2.1 By Type – Global Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2023
4.2.2 By Type – Global Small Molecule Active Pharmaceutical Ingredient Revenue, 2024-2029
4.2.3 By Type – Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
4.3 By Type – Global Small Molecule Active Pharmaceutical Ingredient Sales & Forecasts
4.3.1 By Type – Global Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2023
4.3.2 By Type – Global Small Molecule Active Pharmaceutical Ingredient Sales, 2024-2029
4.3.3 By Type – Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
4.4 By Type – Global Small Molecule Active Pharmaceutical Ingredient Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Small Molecule Active Pharmaceutical Ingredient Market Size, 2022 & 2029
5.1.2 Cardiovascular Diseases
5.1.3 Respiratory Disorders
5.1.4 Infectious Diseases
5.1.5 Others
5.2 By Application – Global Small Molecule Active Pharmaceutical Ingredient Revenue & Forecasts
5.2.1 By Application – Global Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2023
5.2.2 By Application – Global Small Molecule Active Pharmaceutical Ingredient Revenue, 2024-2029
5.2.3 By Application – Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
5.3 By Application – Global Small Molecule Active Pharmaceutical Ingredient Sales & Forecasts
5.3.1 By Application – Global Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2023
5.3.2 By Application – Global Small Molecule Active Pharmaceutical Ingredient Sales, 2024-2029
5.3.3 By Application – Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
5.4 By Application – Global Small Molecule Active Pharmaceutical Ingredient Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Small Molecule Active Pharmaceutical Ingredient Market Size, 2022 & 2029
6.2 By Region – Global Small Molecule Active Pharmaceutical Ingredient Revenue & Forecasts
6.2.1 By Region – Global Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2023
6.2.2 By Region – Global Small Molecule Active Pharmaceutical Ingredient Revenue, 2024-2029
6.2.3 By Region – Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
6.3 By Region – Global Small Molecule Active Pharmaceutical Ingredient Sales & Forecasts
6.3.1 By Region – Global Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2023
6.3.2 By Region – Global Small Molecule Active Pharmaceutical Ingredient Sales, 2024-2029
6.3.3 By Region – Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2029
6.4.2 By Country – North America Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2029
6.4.3 US Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.4.4 Canada Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.4.5 Mexico Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2029
6.5.2 By Country – Europe Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2029
6.5.3 Germany Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.5.4 France Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.5.5 U.K. Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.5.6 Italy Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.5.7 Russia Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.5.8 Nordic Countries Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.5.9 Benelux Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2029
6.6.2 By Region – Asia Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2029
6.6.3 China Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.6.4 Japan Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.6.5 South Korea Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.6.6 Southeast Asia Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.6.7 India Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2029
6.7.2 By Country – South America Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2029
6.7.3 Brazil Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.7.4 Argentina Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2029
6.8.3 Turkey Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.8.4 Israel Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.8.5 Saudi Arabia Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.8.6 UAE Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson Matthey
7.1.1 Johnson Matthey Company Summary
7.1.2 Johnson Matthey Business Overview
7.1.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.1.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.1.5 Johnson Matthey Key News & Latest Developments
7.2 Siegfried Holding AG
7.2.1 Siegfried Holding AG Company Summary
7.2.2 Siegfried Holding AG Business Overview
7.2.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.2.4 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.2.5 Siegfried Holding AG Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.3.4 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Sanofi S.A.
7.4.1 Sanofi S.A. Company Summary
7.4.2 Sanofi S.A. Business Overview
7.4.3 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.4.4 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi S.A. Key News & Latest Developments
7.5 Novartis AG,
7.5.1 Novartis AG, Company Summary
7.5.2 Novartis AG, Business Overview
7.5.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.5.4 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.5.5 Novartis AG, Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.6.4 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Boehringer Ingelheim GmbH
7.7.1 Boehringer Ingelheim GmbH Company Summary
7.7.2 Boehringer Ingelheim GmbH Business Overview
7.7.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.7.4 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.7.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.8.4 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 Albany Molecular Research Inc.
7.9.1 Albany Molecular Research Inc. Company Summary
7.9.2 Albany Molecular Research Inc. Business Overview
7.9.3 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.9.4 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.9.5 Albany Molecular Research Inc. Key News & Latest Developments
7.10 Bachem Holding AG
7.10.1 Bachem Holding AG Company Summary
7.10.2 Bachem Holding AG Business Overview
7.10.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.10.4 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.10.5 Bachem Holding AG Key News & Latest Developments
7.11 PCAS
7.11.1 PCAS Company Summary
7.11.2 PCAS Small Molecule Active Pharmaceutical Ingredient Business Overview
7.11.3 PCAS Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.11.4 PCAS Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.11.5 PCAS Key News & Latest Developments
7.12 Patheon N.V.
7.12.1 Patheon N.V. Company Summary
7.12.2 Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Business Overview
7.12.3 Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.12.4 Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.12.5 Patheon N.V. Key News & Latest Developments
7.13 AstraZeneca
7.13.1 AstraZeneca Company Summary
7.13.2 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Business Overview
7.13.3 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.13.4 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.13.5 AstraZeneca Key News & Latest Developments
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Company Summary
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.14.4 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.14.5 Johnson & Johnson Key News & Latest Developments
7.15 Merck & Co
7.15.1 Merck & Co Company Summary
7.15.2 Merck & Co Business Overview
7.15.3 Merck & Co Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.15.4 Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.15.5 Merck & Co Key News & Latest Developments
7.16 BASF SE
7.16.1 BASF SE Company Summary
7.16.2 BASF SE Business Overview
7.16.3 BASF SE Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.16.4 BASF SE Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.16.5 BASF SE Key News & Latest Developments
7.17 Catalent Inc.
7.17.1 Catalent Inc. Company Summary
7.17.2 Catalent Inc. Business Overview
7.17.3 Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.17.4 Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.17.5 Catalent Inc. Key News & Latest Developments
7.18 Teva Pharmaceuticals
7.18.1 Teva Pharmaceuticals Company Summary
7.18.2 Teva Pharmaceuticals Business Overview
7.18.3 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.18.4 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.18.5 Teva Pharmaceuticals Key News & Latest Developments
7.19 Roche
7.19.1 Roche Company Summary
7.19.2 Roche Business Overview
7.19.3 Roche Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.19.4 Roche Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.19.5 Roche Key News & Latest Developments
7.20 Cambrex Corporation
7.20.1 Cambrex Corporation Company Summary
7.20.2 Cambrex Corporation Business Overview
7.20.3 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.20.4 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.20.5 Cambrex Corporation Key News & Latest Developments
7.21 GILEAD Science Inc.
7.21.1 GILEAD Science Inc. Company Summary
7.21.2 GILEAD Science Inc. Business Overview
7.21.3 GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.21.4 GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.21.5 GILEAD Science Inc. Key News & Latest Developments
8 Global Small Molecule Active Pharmaceutical Ingredient Production Capacity, Analysis
8.1 Global Small Molecule Active Pharmaceutical Ingredient Production Capacity, 2018-2029
8.2 Small Molecule Active Pharmaceutical Ingredient Production Capacity of Key Manufacturers in Global Market
8.3 Global Small Molecule Active Pharmaceutical Ingredient Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Small Molecule Active Pharmaceutical Ingredient Supply Chain Analysis
10.1 Small Molecule Active Pharmaceutical Ingredient Industry Value Chain
10.2 Small Molecule Active Pharmaceutical Ingredient Upstream Market
10.3 Small Molecule Active Pharmaceutical Ingredient Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Small Molecule Active Pharmaceutical Ingredient Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • パクリタキセル注射（アルブミン結合）のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品
  • 持続携行式腹膜透析（CAPD）のグローバル市場展望 2023年-2029年：腹膜透析セット、装置、カテーテル、その他
  • カリウム競合性酸ブロッカー（P-CAB）のグローバル市場展望 2023年-2029年：レヴァプラザン、ヴォノプラザン、テゴプラザン
  • 医薬品用アクセス制限バリアシステム（RABS）のグローバル市場展望 2023年-2029年：オープン、クローズ
  • ターシャリーブチルホスフィン（TBP）のグローバル市場展望 2023年-2029年：95%-99%、>99%
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8667 )"低分子医薬品有効成分（API）のグローバル市場展望 2023年-2029年：標準原薬、高効能原薬" (英文：Small Molecule Active Pharmaceutical Ingredient Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。